Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

KRSNAA DIAGNOSTICS Gains 5%; BSE HEALTHCARE Index Down 0.1%
Wed, 30 Oct 11:59

KRSNAA DIAGNOSTICS Gains 5%; BSE HEALTHCARE Index Down 0.1%Image source: alexsl/www.istockphoto.com

KRSNAA DIAGNOSTICS share price has zoomed 5% and is presently trading at Rs 935.8.

Meanwhile, the BSE HEALTHCARE index is at 43,154.1 (down 0.1%).

Among the top gainers in the BSE HEALTHCARE index today are POLY MEDICURE (up 8.1%) and GSK Pharma (up 3.7%).

Cipla (down 3.9%) and Jubilant Pharmova (down 3.6%) are among the top losers today.

Over the last one year, KRSNAA DIAGNOSTICS has moved up from Rs 700.3 to Rs 935.8, registering a gain of Rs 235.5 (up 33.6%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,385.2 to 43,154.1, registering a gain of 57.6% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 179.9%), SUVEN PHARMACEUTICALS (up 125.9%) and Glenmark Pharma (up 125.2%).

Dear Reader: If You Invest in Midcap Stocks, this is for You

What About the Benchmark Indices?

The BSE Sensex is at 80,243.9 (down 0.2%).

The top losers among the BSE Sensex today are ICICI Bank (down 1.7%) and Axis Bank (down 1.1%). The most traded stocks in the BSE Sensex are Power Grid Corp. and Tata Motors.

In the meantime, NSE Nifty is at 24,437.3 (down 0.1%). Cipla and SBI LIFE INSURANCE are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 64,112.7 to 80,243.9, registering a gain of 16,131.3 points (up 25.2%).

KRSNAA DIAGNOSTICS Financial Update...

KRSNAA DIAGNOSTICS net profit grew 86.7% YoY to Rs 196 million for the quarter ended September 2024, compared to a profit of Rs 105 million a year ago. Net sales rose 19.9% to Rs 1,863 million during the period as against Rs 1,554 million in July-September 2023.

For the year ended March 2024, KRSNAA DIAGNOSTICS reported 8.5% decrease in net profit to Rs 568 million compared to net profit of Rs 621 million during FY23. Revenue of the company grew 27.2% to Rs 6,196 million during FY24.

The current Price to earnings ratio of KRSNAA DIAGNOSTICS, based on rolling 12 month earnings, stands at 43.7.


Equitymaster requests your view! Post a comment on "KRSNAA DIAGNOSTICS Gains 5%; BSE HEALTHCARE Index Down 0.1%". Click here!